Cargando…

Mesenchymal stem cells in multiple sclerosis - translation to clinical trials

Multiple sclerosis is a chronic inflammatory disease of the central nervous system, characterized by an aberrant activation of the immune system and combining demyelination with neurodegeneration. Studies on experimental models of multiple sclerosis revealed immunomodulatory and immunosuppressive pr...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dulamea, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Carol Davila University Press 2015
Materias:	General Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397514/ https://www.ncbi.nlm.nih.gov/pubmed/25914733

Ejemplares similares

Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
por: Alanazi, Asma, et al.
Publicado: (2022)

The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies
por: Dulamea, Adriana Octaviana
Publicado: (2017)

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
por: Uccelli, Antonio, et al.
Publicado: (2019)

Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis
por: Planchon, Sarah M, et al.
Publicado: (2018)

Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)

Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
por: Llufriu, Sara, et al.
Publicado: (2014)

The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis
por: Naderi, Nima
Publicado: (2015)

Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies
por: Gugliandolo, Agnese, et al.
Publicado: (2020)

Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis
por: Baharlooi, Hussein, et al.
Publicado: (2022)

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
por: Harris, Violaine K., et al.
Publicado: (2018)

Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation
por: Rady, Dina, et al.
Publicado: (2020)

Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
por: Riordan, Neil H., et al.
Publicado: (2018)

Mesenchymal stem cells in dogs with demyelinating leukoencephalitis as an experimental model of multiple sclerosis
por: Pinheiro, Luane Lopes, et al.
Publicado: (2019)

Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
por: Zhou, Yang, et al.
Publicado: (2019)

Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis
por: Cohen, Jeffrey A, et al.
Publicado: (2022)

Correction to: Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis
por: Riordan, Neil H., et al.
Publicado: (2021)

Multiple sclerosis at the crossroads of scientific evidence and clinical translation
por: Sellner, Johann
Publicado: (2022)

Mesenchymal Stem Cell-derived Neural Progenitor Cells in Progressive Multiple Sclerosis: Great Expectations
por: Baldassari, Laura E., et al.
Publicado: (2018)

Advancing mesenchymal stem cell therapy for asthma towards clinical translation
por: MacLoughlin, Ronan
Publicado: (2022)

Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis
por: Petrou, Panayiota, et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Islam, Md Asiful, et al.
Publicado: (2023)

Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
por: Dahbour, Said, et al.
Publicado: (2017)

Mesenchymal stem cells in systemic sclerosis therapy
por: Dudek, Daniel Witold, et al.
Publicado: (2020)

Tuberous sclerosis with negative genetic testing and multiple cerebral cavernomas: A new association (Case report)
por: Arbune, Anca Adriana, et al.
Publicado: (2021)

Multiple sclerosis: present and future
por: Scarlato, G, et al.
Publicado: (1984)

Promotion of Remyelination by Adipose Mesenchymal Stem Cell Transplantation in A Cuprizone Model of Multiple Sclerosis
por: Hedayatpour, Azim, et al.
Publicado: (2013)

Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica
por: Dulamea, Adriana Octaviana, et al.
Publicado: (2015)

Effect of Multiple Intraperitoneal Injections of Human Bone Marrow Mesenchymal Stem Cells on Cuprizone Model of Multiple Sclerosis
por: Marzban, Mohsen, et al.
Publicado: (2018)

Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis
por: Petrou, Panayiota, et al.
Publicado: (2021)

Molecular mechanism for the multiple sclerosis risk variant rs17594362
por: Kim, Dongkyeong, et al.
Publicado: (2019)

Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis
por: Harris, Violaine K., et al.
Publicado: (2023)

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Opportunities and Challenges for Clinical Translation
por: Maumus, Marie, et al.
Publicado: (2020)

Mesenchymal Stem Cells for Cardiac Regeneration: Translation to Bedside Reality
por: Elnakish, Mohammad T., et al.
Publicado: (2012)

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
por: Birmpili, Dafni, et al.
Publicado: (2022)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

Clinical trials in multiple sclerosis: milestones
por: Zhang, Yinan, et al.
Publicado: (2018)

Evolution of clinical trials in multiple sclerosis
por: Zhang, Yinan, et al.
Publicado: (2019)

Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis
por: Salinas Tejedor, Laura, et al.
Publicado: (2016)

Abstract 14 Umbilical Cord Mesenchymal Stromal/Stem Cells Application for Spasticity Treatment in Multiple Sclerosis
por: Petriv, Taras, et al.
Publicado: (2022)

Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis
por: Vlaic, S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_03kcguqrsgebod7rc2gu2f9ide